<HTML xmlns:o = "urn:schemas-microsoft-com:office:office"><HEAD><TITLE>Sarbacane Newslettter 04</TITLE>
<STYLE type=text/css>
<!--
td {
font-family: Verdana, Arial, Helvetica, sans-serif;
font-size: 11px;
color: #000000;
text-decoration: none
}
.text {
font-family: Verdana, Arial, Helvetica, sans-serif;
font-size: 11px;
color: #000000;
text-decoration: none
}
.tiret {
color: #6699FF
}
a:link { color: #006699; text-decoration: underline}
a:visited { color: #006699; text-decoration: underline}
a:hover { color: #006699; text-decoration: underline}
-->
</STYLE>
</HEAD>
<BODY aLink=#0000ff link=#0000ff bgColor=#afcae6 text=#000000 vLink=#800080>
<TABLE height=80 cellSpacing=0 cellPadding=0 width=601 align=center
bgColor=#ffffff background="" border=0>
<TBODY>
<TR height=99>
<TD width=201>
<DIV align=center><FONT size=+2
face="Verdana, Arial, Helvetica, sans-serif"><IMG border="0" hspace="0" src="cid:5B1EED4CF8B993AB305DA82107AAF1E3@user-PC" width="56" height="90"><FONT size=2> </FONT></FONT></DIV></TD>
<TD bgColor=#ebf2f9 align=center>
<DIV><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman','serif'; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA"><FONT
size=5><FONT color=#0080c0><STRONG><FONT color=#ff8040 face=Verdana><SPAN
lang=FR-BE
style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman','serif'; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA"><FONT
color=#0080c0><STRONG><A href="C:\Users\user\Documents\Sarbacane 3\Campaigns\Campagne ATA MAG 03 2013\Html\Cache\http___www.nutralica.eu_dossiers-scientifiques_magn%C3%A9sium-ac%C3%A9tyltaurinate-ata-mg.html"><FONT
size=6 face=Verdana>ATA Mg</FONT></A></STRONG><SPAN
style="FONT-SIZE: 16pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #4f81bd; mso-themecolor: accent1"><STRONG><A href="C:\Users\user\Documents\Sarbacane 3\Campaigns\Campagne ATA MAG 03 2013\Html\Cache\http___www.nutralica.eu_dossiers-scientifiques_magn%C3%A9sium-ac%C3%A9tyltaurinate-ata-mg.html"><FONT
size=6>®</FONT></A></STRONG></SPAN></FONT></SPAN></FONT></STRONG><SPAN
style="FONT-SIZE: 16pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #4f81bd; mso-themecolor: accent1">
<BR><FONT color=#000000 size=5><FONT size=1><BR></FONT>effet sur
l'hyperactivité </FONT></SPAN></FONT></FONT></SPAN></DIV>
<DIV><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman','serif'; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA"><FONT
size=5><FONT color=#0080c0><SPAN
style="FONT-SIZE: 16pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #4f81bd; mso-themecolor: accent1"><FONT
color=#000000 size=5>neuronale</FONT></SPAN></FONT></FONT></SPAN><SPAN
lang=FR-BE
style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman','serif'; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA"><BR></DIV></SPAN></TD></TR></TBODY></TABLE>
<TABLE height=767 cellSpacing=2 cellPadding=0 width=604 align=center
background="" border=0>
<TBODY>
<TR height=391 bgColor=#ffffff>
<TD vAlign=top width=196>
<TABLE class=text cellSpacing=0 cellPadding=10 width=200 align=center
border=0>
<TBODY>
<TR height=115>
<TD bgColor=#ebf2f9>
<DIV><STRONG>Bonjour, </STRONG></DIV>
<DIV> </DIV>
<DIV align=left><STRONG>Nous avons le plaisir de vous envoyer
la News-letter de <BR><BR></STRONG><STRONG><EM>HealthCare
</EM><FONT color=#0000ff>Institute</FONT></STRONG></DIV>
<DIV><FONT
style="BACKGROUND-COLOR: #ebf2f9"></FONT> </DIV></TD></TR>
<TR height=306>
<TD bgColor=#ffffff>
<DIV><BR> </DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV>
<TABLE height=70 cellSpacing=2 cellPadding=0 width="100%"
bgColor=#afcae6 border=0>
<TBODY>
<TR>
<TD bgColor=#ffffff align=center>
<DIV><FONT size=1><STRONG><FONT color=#fdba33 size=3
face=Wingdings></FONT></STRONG></FONT> </DIV>
<DIV align=center><FONT size=1><STRONG><FONT color=#fdba33
size=3 face=Wingdings>F</FONT></STRONG> Dossier
scientifique <BR>sur <BR></FONT><FONT
size=1><BR><FONT color=#008000 size=2><STRONG><A href="http://tk3.hyamau.com/sy/ev?3&9323-109&58&MLl8NcymIaRiuvEVVU0ZzA">ATA
Mg</A></STRONG></FONT></FONT></DIV>
<DIV align=center> </DIV>
<DIV><FONT color=#339966 size=2></FONT></DIV><FONT
color=#339966 size=2></FONT><FONT color=#339966 size=2></FONT>
<DIV><FONT color=#000000 size=3></FONT> </DIV>
<DIV><FONT
size=3></FONT> </DIV></TD></TR></TBODY></TABLE></DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV>
<TABLE height=70 cellSpacing=2 cellPadding=0 width="100%"
bgColor=#afcae6 border=0>
<TBODY>
<TR>
<TD bgColor=#ffffff align=center>
<DIV></DIV>
<DIV><FONT size=3><STRONG><FONT color=#fdba33
face=Wingdings></FONT></STRONG></FONT></DIV>
<DIV align=center><FONT size=1><STRONG><FONT color=#fdba33
size=3 face=Wingdings><FONT face=Wingdings><FONT
size=1></FONT></STRONG></FONT> </DIV></FONT></FONT>
<DIV align=center><FONT size=1><STRONG><FONT color=#fdba33
size=3 face=Wingdings>F</FONT></STRONG> Dossiers scientifiques
de<BR> </FONT></DIV>
<DIV align=center><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: rgb(51,153,102)"><STRONG><FONT
size=2><FONT color=#0080c0><A href="http://tk3.hyamau.com/sy/ev?3&9323-109&59&MLl8NcymIaRiuvEVVU0ZzA"><EM><FONT
color=#000000>HealthCare<BR></FONT></EM>Institute</A></FONT></FONT></STRONG></SPAN></DIV><FONT
color=#339966 size=2>
<DIV> </DIV>
<DIV><IMG border="0" hspace="0" src="cid:5B1EED4CF8B993AB305DA82107AAF1E3@user-PC"><BR><BR></DIV></FONT></TD></TR></TBODY></TABLE></DIV>
<DIV> </DIV>
<DIV> </DIV>
<DIV> </DIV></TD></TR></TBODY></TABLE>
<BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr>
<DIV class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"
dir=ltr align=left><EM><FONT size=1>(*) </FONT><SPAN><FONT
size=1>Bibliographie<BR></FONT></SPAN></EM></DIV>
<DIV class=MsoNormal style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt"
dir=ltr align=right><FONT size=1><SPAN lang=fr
style="FONT-SIZE: 6pt; FONT-FAMILY: Verdana; mso-ascii-font-family: Verdana; language: fr; mso-default-font-family: Verdana; mso-latin-font-family: Verdana; mso-greek-font-family: Verdana; mso-cyrillic-font-family: Verdana; mso-latinext-font-family: Verdana"><STRONG><FONT
color=#fdba33 size=3
face=Wingdings>F</FONT></STRONG></SPAN><EM> </EM></FONT><A href="mailto:info@nutralica.eu"><EM><FONT
size=1>info@nutralica.eu</FONT></EM></A><FONT
size=1> </FONT></DIV></BLOCKQUOTE></TD>
<TD bgColor=#ffffff vAlign=top>
<TABLE class=text cellSpacing=0 cellPadding=10 width="100%" align=left
border=0>
<TBODY>
<TR height=502>
<TD bgColor=#ffffff>
<DIV><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#000000><SPAN lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #ff8040; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-font-family: 'Times New Roman'"><FONT
size=2><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><FONT size=2><FONT
size=2><FONT size=5><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#0080c0 size=3><STRONG>ATA Mg®</STRONG></FONT></SPAN>
</FONT></FONT></FONT><FONT size=2><FONT color=#000000><SPAN
style="FONT-FAMILY: verdana,geneva"><FONT size=2>Ethane sulfonic
acid, 2 (acetylamino) magnesium 2-1 , </FONT></SPAN>vecteur autorisé
(Scientific Opinion of the Panel on Food Additives and Nutrient
Sources added to Food). The EFSA (European Food Safety Authority)
Journal (2009) 947,1-30) et, par la Commission Européenne, Annexe II
du règlement (CE) n°1170/2009.</FONT></FONT></SPAN></FONT><FONT
size=2><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-FAMILY: "></DIV>
<DIV>
<DIV> </DIV>
<DIV><IMG border="0" hspace="0" alt="" src="cid:CB3F13A75D1653596A19370F0FB1541F@user-PC" width="326" height="149"></SPAN></SPAN></FONT></SPAN></DIV>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"></DIV>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN lang=NL
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; mso-ansi-language: NL; mso-fareast-font-family: Verdana; mso-fareast-language: FR; mso-bidi-font-family: Verdana; mso-font-kerning: 12.0pt"><SPAN
lang=FR-BE
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; LINE-HEIGHT: 115%; mso-ansi-language: FR-BE"><FONT
color=#000000><FONT
color=#0080ff><STRONG></STRONG></FONT></FONT></SPAN></SPAN> </DIV>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"><SPAN lang=NL
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; mso-ansi-language: NL; mso-fareast-font-family: Verdana; mso-fareast-language: FR; mso-bidi-font-family: Verdana; mso-font-kerning: 12.0pt"><SPAN
lang=FR-BE
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; LINE-HEIGHT: 115%; mso-ansi-language: FR-BE"><FONT
color=#000000><FONT color=#0080ff>
<DIV align=left><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-FAMILY: "><FONT size=2><FONT color=#000000>est un
analogue magnésique de la </FONT><FONT color=#000000><A href="http://tk3.hyamau.com/sy/ev?3&9323-109&57&MLl8NcymIaRiuvEVVU0ZzA">Taurine</A>
</FONT><FONT color=#000000>avec les caractéristiques suivantes
:</FONT></DIV>
<UL>
<LI>
<DIV class=MsoNormal><FONT color=#000000>Dérivé β aminé soufré
</FONT></DIV>
<LI>
<DIV class=MsoNormal><FONT color=#000000>Acide sulfonique (non
carboxylique)</FONT></DIV>
<LI>
<DIV class=MsoNormal><FONT
color=#000000><EM>N</EM>-acétylé</FONT></DIV>
<LI>
<DIV class=MsoNormal><FONT color=#000000>Sans le caractère
amphotère « zwitterion » de la Taurine , ce qui
permet d'optimiser le caractère taurinergique intra-cellulaire.
</FONT></DIV></LI></UL>
<DIV></FONT></SPAN></SPAN><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><FONT
size=2><FONT size=2><FONT size=5><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
size=3><FONT color=#000000><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><SPAN
lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #ff8040; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-font-family: 'Times New Roman'"><FONT
size=2><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><FONT size=2><FONT
size=2><FONT size=5><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
size=3><STRONG><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#000000><SPAN lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #ff8040; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-font-family: 'Times New Roman'"><FONT
size=2><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><FONT size=2><FONT
size=2><FONT size=5><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#0080c0 size=3><STRONG>ATA
Mg®</STRONG></FONT></SPAN></FONT></FONT></FONT></SPAN></FONT></SPAN></FONT></SPAN></SPAN></STRONG></FONT></SPAN></FONT></FONT></FONT></SPAN></FONT></SPAN></SPAN></SPAN>
<FONT size=2>qui est l'association de la Taurine <EM>N-</EM>acétylée
et du Mg++ , permet de une</FONT> <FONT
size=2>optimalisation de l'apport intracellulaire du Mg++ et de la
Taurine par un </FONT></FONT><SPAN
style="FONT-SIZE: 10pt"><SPAN
style="FONT-FAMILY: verdana,geneva"><FONT color=#000000>passage
facilité dans la barrière hémo-méningée et l’entrée dans les
cellules
neuronales.<BR></FONT></SPAN></SPAN></DIV></FONT></SPAN></FONT></FONT></FONT></SPAN></SPAN></FONT></FONT></SPAN></SPAN></FONT></SPAN></SPAN><FONT
size=2><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-FAMILY: "></DIV>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal" align=left><SPAN
style="FONT-SIZE: 25pt; FONT-FAMILY: Arial; COLOR: black; mso-fareast-font-family: +mn-ea; mso-ascii-font-family: Arial; language: fr-BE; mso-bidi-font-family: Arial; mso-font-kerning: 12.0pt; mso-style-textfill-fill-color: black; mso-style-textfill-fill-alpha: 100.0%; mso-fareast-theme-font: minor-fareast; mso-bidi-theme-font: minor-bidi; mso-style-textfill-type: solid"><FONT
size=4><FONT size=2><SPAN lang=FR-BE
style="FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-font-kerning: 12.0pt; mso-fareast-theme-font: minor-fareast">
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"></SPAN></DIV></DIV></FONT></FONT></SPAN></SPAN></SPAN></FONT><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#0080c0><STRONG><SPAN style="FONT-SIZE: 10pt"><B><SPAN
style="FONT-FAMILY: verdana,geneva"></SPAN></B></SPAN></STRONG></FONT></SPAN></SPAN></SPAN><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#000000><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><STRONG><FONT
color=#008000>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"> </DIV>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal">
<TABLE borderColor=#0080c0 height=141 cellSpacing=1 cellPadding=1
width=369 background="" border=1>
<TBODY>
<TR>
<TD><FONT color=#000000><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#008000><FONT face=Verdana><SPAN lang=FR-BE
style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman','serif'; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA"><FONT
color=#0080c0><FONT color=#ff8040><SPAN lang=FR-BE
style="FONT-SIZE: 18pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #ff8040; mso-ansi-language: FR-BE; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-font-family: 'Times New Roman'"><FONT
size=1>
<DIV class=MsoNormal
style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"
align=left><BR></FONT></SPAN><FONT size=2><SPAN lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #467bfe; mso-ansi-language: FR-BE; mso-fareast-font-family: +mn-ea; mso-fareast-language: FR; mso-bidi-font-family: Arial; mso-font-kerning: 12.0pt"><STRONG><FONT
color=#0080c0><FONT size=5>ATA Mg®</FONT></FONT><FONT
color=#339966> </FONT></STRONG></SPAN></FONT></DIV>
<DIV class=MsoNormal
style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"
align=left><FONT color=#339966 size=2><SPAN lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #467bfe; mso-ansi-language: FR-BE; mso-fareast-font-family: +mn-ea; mso-fareast-language: FR; mso-bidi-font-family: Arial; mso-font-kerning: 12.0pt"><STRONG></STRONG></SPAN></FONT> </DIV>
<DIV class=MsoNormal
style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"
align=justify><FONT size=2><SPAN lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #467bfe; mso-ansi-language: FR-BE; mso-fareast-font-family: +mn-ea; mso-fareast-language: FR; mso-bidi-font-family: Arial; mso-font-kerning: 12.0pt"><FONT
color=#000000 size=2>est un inhibiteur de l’acide kaïnique,
neurotransmetteur impliqué dans l’<EM>hyperactivité
neuronale</EM> (stress, fatigue, migraines, migraines
photiques, céphalées, troubles du rythme
cardiaque, épilepsies, convulsions,…)
et, </FONT><FONT color=#000000 size=2><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR"><SPAN
lang=FR-BE
style="FONT-SIZE: 14pt; mso-ansi-language: FR-BE"><FONT
size=2><FONT size=2><FONT size=5><SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #339966"><FONT
color=#000000>possède <SPAN
style="FONT-SIZE: 10pt; FONT-FAMILY: verdana,geneva">des
propriétés cytovasculaires et
nootropes.</SPAN></FONT></SPAN></FONT></FONT></FONT></SPAN></SPAN></FONT></DIV></SPAN></FONT><FONT
size=2><SPAN lang=FR-BE
style="FONT-SIZE: 12pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: #467bfe; mso-ansi-language: FR-BE; mso-fareast-font-family: +mn-ea; mso-fareast-language: FR; mso-bidi-font-family: Arial; mso-font-kerning: 12.0pt">
<DIV class=MsoNormal
style="TEXT-ALIGN: center; MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"
align=left></SPAN></FONT></FONT></FONT></SPAN></FONT> </DIV></FONT></SPAN></SPAN></SPAN></SPAN></SPAN></SPAN></FONT></TD></TR></TBODY></TABLE></DIV>
<DIV class=MsoNormal
style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: normal"> </DIV></FONT></STRONG></SPAN></SPAN></SPAN></SPAN></SPAN></SPAN></FONT></SPAN></SPAN></SPAN></DIV></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE>
<TABLE height=60 cellSpacing=0 cellPadding=10 width=601 align=center
bgColor=#ffffff background="" border=0>
<TBODY>
<TR>
<TD width="40%">
<DIV align=center><FONT size=1><SPAN
style="FONT-SIZE: 7pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; LINE-HEIGHT: 115%; mso-ansi-language: FR; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA; mso-bidi-font-family: 'Times New Roman'; mso-bidi-font-size: 8.0pt"><SPAN
style="FONT-SIZE: 7pt; FONT-FAMILY: 'Verdana','sans-serif'; COLOR: black; LINE-HEIGHT: 115%; mso-ansi-language: FR; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: FR; mso-bidi-language: AR-SA; mso-bidi-font-family: 'Times New Roman'; mso-bidi-font-size: 8.0pt">Pour
se désinscrire de [to unsubscribe] cette News-letter <A href="http://tk3.hyamau.com/sy/ev?3&9323-109&44&MLl8NcymIaRiuvEVVU0ZzA&pkg-exim4-maintainers@lists.alioth.debian.org&news-letter@nutralica.eu&fr"><SPAN style="COLOR: #006699">cliquez
ici</SPAN></A>.<BR>Copyright © Nutralica
2002-2013.</SPAN></SPAN></FONT></DIV></TD></TR></TBODY></TABLE><img src="http://tk3.hyamau.com/sy/ev?3&9323-109&-1&MLl8NcymIaRiuvEVVU0ZzA" border="0" width="1" height="1">
</BODY></HTML>